Alterations in T cells of cancer-bearers: whence specificity?
- 1 August 1996
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 17 (8) , 365-368
- https://doi.org/10.1016/0167-5699(96)10013-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapyImmunology Today, 1996
- Variable expression of CD3‐ζ chain in tumor‐infiltrating lymphocytes (TIL) derived from renal‐cell carcinoma: Relationship with til phenotype and functionInternational Journal of Cancer, 1995
- Alterations in the signal‐transducing molecules of T cells and nk cells in colorectal tumor‐infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the diseaseInternational Journal of Cancer, 1995
- Impaired cytokine production in whole blood cell cultures of patients with urological carcinomasZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- The T cell receptor/CD3 complex is composed of at least two autonomous transduction modulesCell, 1992
- Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controlsJournal of Clinical Laboratory Analysis, 1992
- Structural Mutations of the T Cell Receptor ζ Chain and Its Role in T Cell ActivationScience, 1990
- Multiple cancers. Tumor burden permits the outgrowth of other cancers.The Journal of Experimental Medicine, 1985
- Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity.The Journal of Experimental Medicine, 1984
- Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.The Journal of Experimental Medicine, 1984